Your session is about to expire
← Back to Search
Behavioral Intervention
EHR-Enabled Support Teams for High Blood Pressure Management
N/A
Waitlist Available
Led By Saul Blecker, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 18
Awards & highlights
Study Summary
This trial will test a new way to help people with high blood pressure better manage their medication.
Who is the study for?
This trial is for adults over 18 with high blood pressure, diagnosed as having a reading of at least 140/90 or already on antihypertensive medication. They must have visited an NYULH outpatient clinic between June 2022 and December 2025. Healthcare workers involved include physicians, medical assistants, nurses at NYULH ambulatory locations.Check my eligibility
What is being tested?
The study tests if using 'teamlets'—small healthcare teams guided by Electronic Health Records (EHR)—helps patients stick to their blood pressure medications better and control their hypertension more effectively in primary care settings across up to 22 NYU clinics.See study design
What are the potential side effects?
Since the intervention involves organizational changes rather than drugs or medical procedures, direct side effects are not expected. However, there may be indirect effects related to changes in medication adherence.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month 18
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 18
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Secondary outcome measures
Average Number of Days Covered (PDC) as a Measure of Medication Adherence
Mean Diastolic Blood Pressure
Mean Systolic Blood Pressure
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
Group II: Usual Care GroupActive Control1 Intervention
Usual Care Clinical Decision Support (CDS) Tools
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,370 Previous Clinical Trials
839,078 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,843 Previous Clinical Trials
47,815,382 Total Patients Enrolled
Saul Blecker, MDPrincipal InvestigatorNYU Langone Health
2 Previous Clinical Trials
2,958 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a healthcare professional at NYULH seeing adult patients.I do not wish to be observed without treatment.I am over 18 and have high blood pressure or am on medication for it.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention Group
- Group 2: Usual Care Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any open slots for enrolment in this trial?
"According to clinicaltrials.gov, the study is no longer seeking participants and has been unenrolling since June 6th 2022 - when it was last updated. Despite this fact, there are still 183 medical trials recruiting at present."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger